Figure 5.
bACC of ResFinder predictions based on ResFinder compound–class-level annotation versus compound-level annotation in K. pneumoniae samples. Compound-level prediction consistently performs better and the increase in bACC ranges between 0.01 for tobramycin resistance prediction and 0.26 for cefepime resistance prediction.
